OncoCyte Corp (OCX)
2.90
-0.10
(-3.33%)
USD |
NASDAQ |
Nov 04, 16:00
2.82
-0.08
(-2.76%)
Pre-Market: 20:00
OncoCyte Shareholders Equity (Quarterly): 22.70M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 22.70M |
| March 31, 2024 | 11.59M |
| December 31, 2023 | 20.47M |
| September 30, 2023 | 37.56M |
| June 30, 2023 | 43.60M |
| March 31, 2023 | 37.93M |
| December 31, 2022 | 34.29M |
| September 30, 2022 | 76.86M |
| June 30, 2022 | 88.10M |
| March 31, 2022 | 56.97M |
| December 31, 2021 | 65.22M |
| September 30, 2021 | 99.35M |
| June 30, 2021 | 102.67M |
| March 31, 2021 | 106.63M |
| December 31, 2020 | 33.48M |
| September 30, 2020 | 34.64M |
| June 30, 2020 | 39.59M |
| March 31, 2020 | 36.62M |
| December 31, 2019 | 30.84M |
| Date | Value |
|---|---|
| September 30, 2019 | 29.34M |
| June 30, 2019 | 33.50M |
| March 31, 2019 | 38.19M |
| December 31, 2018 | 3.423M |
| September 30, 2018 | 7.523M |
| June 30, 2018 | 6.846M |
| March 31, 2018 | 9.022M |
| December 31, 2017 | 4.403M |
| September 30, 2017 | 8.048M |
| June 30, 2017 | 5.639M |
| March 31, 2017 | 8.773M |
| December 31, 2016 | 9.862M |
| September 30, 2016 | 12.68M |
| June 30, 2016 | 4.467M |
| March 31, 2016 | 6.895M |
| December 31, 2015 | 10.42M |
| September 30, 2015 | 8.942M |
| December 31, 2014 | -1.074M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
11.59M
Minimum
Mar 2024
106.63M
Maximum
Mar 2021
51.53M
Average
37.93M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Fonar Corp | 165.97M |
| XWELL Inc | 8.798M |
| ProPhase Labs Inc | 44.08M |
| Applied DNA Sciences Inc | 12.39M |
| Veracyte Inc | 1.133B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 74.72M |
| Total Liabilities (Quarterly) | 52.02M |
| Current Ratio | 1.385 |